Abstract
Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID‐19
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have